Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Xuan Ying PohI Russel LeeClarissa LimJefanie TeoSuma RaoPo Ying ChiaSean W X OngTau Hong LeeRay J H LinLisa F P NgEe Chee RenRaymond T P LinLin-Fa WangLaurent ReniaDavid Chien LyeBarnaby E YoungPublished in: Trials (2022)
ClinicalTrials.gov NCT05142319 . Registered on 2 Dec 2021.